ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Transdermal Patch Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-13R16591
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Transdermal Patch Market Research Report 2024
BUY CHAPTERS

Global Drug Transdermal Patch Market Research Report 2025

Code: QYRE-Auto-13R16591
Report
September 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hisamitsu
Mylan NV
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
TEIKOKU SEIYAKU
Bayer
Lingrui
Sanofi
Zhejiang Ausun Pharmaceutical
Endo International
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
ProStrakan
Allergan plc

Drug Transdermal Patch Market

The global market for Drug Transdermal Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Transdermal therapeutic system (TTS or transdermal delivery system, TDS) or transdermal absorption preparation refers to the use of pharmaceutical, physical and chemical methods to promote the penetration of drugs at a constant rate (or close to a constant rate). It is a new dosage form that enters the circulatory system through the skin surface and produces systemic or local therapeutic effects. In a narrow sense, transdermal drug delivery forms are patches or patches; in a broad sense, TDS includes not only patches (tablets), but also ointments, plasters, liniments and aerosols, as well as non-innovative agents such as traditional patches. .
North American market for Drug Transdermal Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drug Transdermal Patch is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Drug Transdermal Patch include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Transdermal Patch.
The Drug Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drug Transdermal Patch Market Report

Report Metric Details
Report Name Drug Transdermal Patch Market
Segment by Type
  • Duragesic
  • Exelon Patch
  • Lindoerm
  • Mohrus
  • Others
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Zhejiang Ausun Pharmaceutical, Endo International), Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, ProStrakan, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drug Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drug Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Drug Transdermal Patch Market report?

Ans: The main players in the Drug Transdermal Patch Market are Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku, Bayer, Lingrui, Sanofi, Zhejiang Ausun Pharmaceutical, Endo International), Huarun 999, Haw Par, Nichiban, Mentholatum, Laboratoires Genevrier, ProStrakan, Allergan

What are the Application segmentation covered in the Drug Transdermal Patch Market report?

Ans: The Applications covered in the Drug Transdermal Patch Market report are Hospital, Clinic

What are the Type segmentation covered in the Drug Transdermal Patch Market report?

Ans: The Types covered in the Drug Transdermal Patch Market report are Duragesic, Exelon Patch, Lindoerm, Mohrus, Others

1 Drug Transdermal Patch Market Overview
1.1 Product Definition
1.2 Drug Transdermal Patch by Type
1.2.1 Global Drug Transdermal Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Duragesic
1.2.3 Exelon Patch
1.2.4 Lindoerm
1.2.5 Mohrus
1.2.6 Others
1.3 Drug Transdermal Patch by Application
1.3.1 Global Drug Transdermal Patch Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Drug Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Drug Transdermal Patch Revenue 2020-2031
1.4.2 Global Drug Transdermal Patch Sales 2020-2031
1.4.3 Global Drug Transdermal Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drug Transdermal Patch Market Competition by Manufacturers
2.1 Global Drug Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drug Transdermal Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drug Transdermal Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drug Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Transdermal Patch, Product Type & Application
2.7 Global Key Manufacturers of Drug Transdermal Patch, Date of Enter into This Industry
2.8 Global Drug Transdermal Patch Market Competitive Situation and Trends
2.8.1 Global Drug Transdermal Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drug Transdermal Patch Players Market Share by Revenue
2.8.3 Global Drug Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Transdermal Patch Market Scenario by Region
3.1 Global Drug Transdermal Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drug Transdermal Patch Sales by Region: 2020-2031
3.2.1 Global Drug Transdermal Patch Sales by Region: 2020-2025
3.2.2 Global Drug Transdermal Patch Sales by Region: 2026-2031
3.3 Global Drug Transdermal Patch Revenue by Region: 2020-2031
3.3.1 Global Drug Transdermal Patch Revenue by Region: 2020-2025
3.3.2 Global Drug Transdermal Patch Revenue by Region: 2026-2031
3.4 North America Drug Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Drug Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drug Transdermal Patch Sales by Country (2020-2031)
3.4.3 North America Drug Transdermal Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Drug Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drug Transdermal Patch Sales by Country (2020-2031)
3.5.3 Europe Drug Transdermal Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Transdermal Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Transdermal Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drug Transdermal Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Drug Transdermal Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Drug Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drug Transdermal Patch Sales by Country (2020-2031)
3.7.3 Latin America Drug Transdermal Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Transdermal Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drug Transdermal Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drug Transdermal Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Transdermal Patch Sales by Type (2020-2031)
4.1.1 Global Drug Transdermal Patch Sales by Type (2020-2025)
4.1.2 Global Drug Transdermal Patch Sales by Type (2026-2031)
4.1.3 Global Drug Transdermal Patch Sales Market Share by Type (2020-2031)
4.2 Global Drug Transdermal Patch Revenue by Type (2020-2031)
4.2.1 Global Drug Transdermal Patch Revenue by Type (2020-2025)
4.2.2 Global Drug Transdermal Patch Revenue by Type (2026-2031)
4.2.3 Global Drug Transdermal Patch Revenue Market Share by Type (2020-2031)
4.3 Global Drug Transdermal Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drug Transdermal Patch Sales by Application (2020-2031)
5.1.1 Global Drug Transdermal Patch Sales by Application (2020-2025)
5.1.2 Global Drug Transdermal Patch Sales by Application (2026-2031)
5.1.3 Global Drug Transdermal Patch Sales Market Share by Application (2020-2031)
5.2 Global Drug Transdermal Patch Revenue by Application (2020-2031)
5.2.1 Global Drug Transdermal Patch Revenue by Application (2020-2025)
5.2.2 Global Drug Transdermal Patch Revenue by Application (2026-2031)
5.2.3 Global Drug Transdermal Patch Revenue Market Share by Application (2020-2031)
5.3 Global Drug Transdermal Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Company Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hisamitsu Drug Transdermal Patch Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Drug Transdermal Patch Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Drug Transdermal Patch Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Drug Transdermal Patch Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Teve (Actavis)
6.5.1 Teve (Actavis) Company Information
6.5.2 Teve (Actavis) Description and Business Overview
6.5.3 Teve (Actavis) Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teve (Actavis) Drug Transdermal Patch Product Portfolio
6.5.5 Teve (Actavis) Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Drug Transdermal Patch Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Lohmann
6.7.1 Lohmann Company Information
6.7.2 Lohmann Description and Business Overview
6.7.3 Lohmann Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lohmann Drug Transdermal Patch Product Portfolio
6.7.5 Lohmann Recent Developments/Updates
6.8 Teikoku Seiyaku
6.8.1 Teikoku Seiyaku Company Information
6.8.2 Teikoku Seiyaku Description and Business Overview
6.8.3 Teikoku Seiyaku Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teikoku Seiyaku Drug Transdermal Patch Product Portfolio
6.8.5 Teikoku Seiyaku Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Drug Transdermal Patch Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Lingrui
6.10.1 Lingrui Company Information
6.10.2 Lingrui Description and Business Overview
6.10.3 Lingrui Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Lingrui Drug Transdermal Patch Product Portfolio
6.10.5 Lingrui Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Company Information
6.11.2 Sanofi Description and Business Overview
6.11.3 Sanofi Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sanofi Drug Transdermal Patch Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Zhejiang Ausun Pharmaceutical
6.12.1 Zhejiang Ausun Pharmaceutical Company Information
6.12.2 Zhejiang Ausun Pharmaceutical Description and Business Overview
6.12.3 Zhejiang Ausun Pharmaceutical Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Ausun Pharmaceutical Drug Transdermal Patch Product Portfolio
6.12.5 Zhejiang Ausun Pharmaceutical Recent Developments/Updates
6.13 Endo International)
6.13.1 Endo International) Company Information
6.13.2 Endo International) Description and Business Overview
6.13.3 Endo International) Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Endo International) Drug Transdermal Patch Product Portfolio
6.13.5 Endo International) Recent Developments/Updates
6.14 Huarun 999
6.14.1 Huarun 999 Company Information
6.14.2 Huarun 999 Description and Business Overview
6.14.3 Huarun 999 Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Huarun 999 Drug Transdermal Patch Product Portfolio
6.14.5 Huarun 999 Recent Developments/Updates
6.15 Haw Par
6.15.1 Haw Par Company Information
6.15.2 Haw Par Description and Business Overview
6.15.3 Haw Par Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Haw Par Drug Transdermal Patch Product Portfolio
6.15.5 Haw Par Recent Developments/Updates
6.16 Nichiban
6.16.1 Nichiban Company Information
6.16.2 Nichiban Description and Business Overview
6.16.3 Nichiban Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Nichiban Drug Transdermal Patch Product Portfolio
6.16.5 Nichiban Recent Developments/Updates
6.17 Mentholatum
6.17.1 Mentholatum Company Information
6.17.2 Mentholatum Description and Business Overview
6.17.3 Mentholatum Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Mentholatum Drug Transdermal Patch Product Portfolio
6.17.5 Mentholatum Recent Developments/Updates
6.18 Laboratoires Genevrier
6.18.1 Laboratoires Genevrier Company Information
6.18.2 Laboratoires Genevrier Description and Business Overview
6.18.3 Laboratoires Genevrier Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Laboratoires Genevrier Drug Transdermal Patch Product Portfolio
6.18.5 Laboratoires Genevrier Recent Developments/Updates
6.19 ProStrakan
6.19.1 ProStrakan Company Information
6.19.2 ProStrakan Description and Business Overview
6.19.3 ProStrakan Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.19.4 ProStrakan Drug Transdermal Patch Product Portfolio
6.19.5 ProStrakan Recent Developments/Updates
6.20 Allergan
6.20.1 Allergan Company Information
6.20.2 Allergan Description and Business Overview
6.20.3 Allergan Drug Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Allergan Drug Transdermal Patch Product Portfolio
6.20.5 Allergan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Transdermal Patch Industry Chain Analysis
7.2 Drug Transdermal Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Transdermal Patch Production Mode & Process Analysis
7.4 Drug Transdermal Patch Sales and Marketing
7.4.1 Drug Transdermal Patch Sales Channels
7.4.2 Drug Transdermal Patch Distributors
7.5 Drug Transdermal Patch Customer Analysis
8 Drug Transdermal Patch Market Dynamics
8.1 Drug Transdermal Patch Industry Trends
8.2 Drug Transdermal Patch Market Drivers
8.3 Drug Transdermal Patch Market Challenges
8.4 Drug Transdermal Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Hisamitsu
Mylan NV
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
TEIKOKU SEIYAKU
Bayer
Lingrui
Sanofi
Zhejiang Ausun Pharmaceutical
Endo International
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
ProStrakan
Allergan plc
List of Tables
 Table 1. Global Drug Transdermal Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drug Transdermal Patch Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drug Transdermal Patch Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drug Transdermal Patch Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drug Transdermal Patch Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drug Transdermal Patch Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drug Transdermal Patch Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drug Transdermal Patch Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drug Transdermal Patch, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drug Transdermal Patch, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drug Transdermal Patch, Product Type & Application
 Table 12. Global Key Manufacturers of Drug Transdermal Patch, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drug Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Transdermal Patch as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drug Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drug Transdermal Patch Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drug Transdermal Patch Sales Market Share by Region (2020-2025)
 Table 19. Global Drug Transdermal Patch Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drug Transdermal Patch Sales Market Share by Region (2026-2031)
 Table 21. Global Drug Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drug Transdermal Patch Revenue Market Share by Region (2020-2025)
 Table 23. Global Drug Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drug Transdermal Patch Revenue Market Share by Region (2026-2031)
 Table 25. North America Drug Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drug Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drug Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drug Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drug Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drug Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drug Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drug Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drug Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drug Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drug Transdermal Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drug Transdermal Patch Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drug Transdermal Patch Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drug Transdermal Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drug Transdermal Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drug Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drug Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drug Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drug Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drug Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drug Transdermal Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drug Transdermal Patch Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drug Transdermal Patch Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drug Transdermal Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drug Transdermal Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drug Transdermal Patch Sales (K Units) by Type (2020-2025)
 Table 51. Global Drug Transdermal Patch Sales (K Units) by Type (2026-2031)
 Table 52. Global Drug Transdermal Patch Sales Market Share by Type (2020-2025)
 Table 53. Global Drug Transdermal Patch Sales Market Share by Type (2026-2031)
 Table 54. Global Drug Transdermal Patch Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drug Transdermal Patch Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drug Transdermal Patch Revenue Market Share by Type (2020-2025)
 Table 57. Global Drug Transdermal Patch Revenue Market Share by Type (2026-2031)
 Table 58. Global Drug Transdermal Patch Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drug Transdermal Patch Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drug Transdermal Patch Sales (K Units) by Application (2020-2025)
 Table 61. Global Drug Transdermal Patch Sales (K Units) by Application (2026-2031)
 Table 62. Global Drug Transdermal Patch Sales Market Share by Application (2020-2025)
 Table 63. Global Drug Transdermal Patch Sales Market Share by Application (2026-2031)
 Table 64. Global Drug Transdermal Patch Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drug Transdermal Patch Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drug Transdermal Patch Revenue Market Share by Application (2020-2025)
 Table 67. Global Drug Transdermal Patch Revenue Market Share by Application (2026-2031)
 Table 68. Global Drug Transdermal Patch Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drug Transdermal Patch Price (US$/Unit) by Application (2026-2031)
 Table 70. Hisamitsu Company Information
 Table 71. Hisamitsu Description and Business Overview
 Table 72. Hisamitsu Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hisamitsu Drug Transdermal Patch Product
 Table 74. Hisamitsu Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan Drug Transdermal Patch Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Drug Transdermal Patch Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Drug Transdermal Patch Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Teve (Actavis) Company Information
 Table 91. Teve (Actavis) Description and Business Overview
 Table 92. Teve (Actavis) Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teve (Actavis) Drug Transdermal Patch Product
 Table 94. Teve (Actavis) Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Drug Transdermal Patch Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Lohmann Company Information
 Table 101. Lohmann Description and Business Overview
 Table 102. Lohmann Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Lohmann Drug Transdermal Patch Product
 Table 104. Lohmann Recent Developments/Updates
 Table 105. Teikoku Seiyaku Company Information
 Table 106. Teikoku Seiyaku Description and Business Overview
 Table 107. Teikoku Seiyaku Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Teikoku Seiyaku Drug Transdermal Patch Product
 Table 109. Teikoku Seiyaku Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Bayer Drug Transdermal Patch Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Lingrui Company Information
 Table 116. Lingrui Description and Business Overview
 Table 117. Lingrui Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Lingrui Drug Transdermal Patch Product
 Table 119. Lingrui Recent Developments/Updates
 Table 120. Sanofi Company Information
 Table 121. Sanofi Description and Business Overview
 Table 122. Sanofi Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sanofi Drug Transdermal Patch Product
 Table 124. Sanofi Recent Developments/Updates
 Table 125. Zhejiang Ausun Pharmaceutical Company Information
 Table 126. Zhejiang Ausun Pharmaceutical Description and Business Overview
 Table 127. Zhejiang Ausun Pharmaceutical Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Zhejiang Ausun Pharmaceutical Drug Transdermal Patch Product
 Table 129. Zhejiang Ausun Pharmaceutical Recent Developments/Updates
 Table 130. Endo International) Company Information
 Table 131. Endo International) Description and Business Overview
 Table 132. Endo International) Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Endo International) Drug Transdermal Patch Product
 Table 134. Endo International) Recent Developments/Updates
 Table 135. Huarun 999 Company Information
 Table 136. Huarun 999 Description and Business Overview
 Table 137. Huarun 999 Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Huarun 999 Drug Transdermal Patch Product
 Table 139. Huarun 999 Recent Developments/Updates
 Table 140. Haw Par Company Information
 Table 141. Haw Par Description and Business Overview
 Table 142. Haw Par Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Haw Par Drug Transdermal Patch Product
 Table 144. Haw Par Recent Developments/Updates
 Table 145. Nichiban Company Information
 Table 146. Nichiban Description and Business Overview
 Table 147. Nichiban Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Nichiban Drug Transdermal Patch Product
 Table 149. Nichiban Recent Developments/Updates
 Table 150. Mentholatum Company Information
 Table 151. Mentholatum Description and Business Overview
 Table 152. Mentholatum Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Mentholatum Drug Transdermal Patch Product
 Table 154. Mentholatum Recent Developments/Updates
 Table 155. Laboratoires Genevrier Company Information
 Table 156. Laboratoires Genevrier Description and Business Overview
 Table 157. Laboratoires Genevrier Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Laboratoires Genevrier Drug Transdermal Patch Product
 Table 159. Laboratoires Genevrier Recent Developments/Updates
 Table 160. ProStrakan Company Information
 Table 161. ProStrakan Description and Business Overview
 Table 162. ProStrakan Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. ProStrakan Drug Transdermal Patch Product
 Table 164. ProStrakan Recent Developments/Updates
 Table 165. Allergan Company Information
 Table 166. Allergan Description and Business Overview
 Table 167. Allergan Drug Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Allergan Drug Transdermal Patch Product
 Table 169. Allergan Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Drug Transdermal Patch Distributors List
 Table 173. Drug Transdermal Patch Customers List
 Table 174. Drug Transdermal Patch Market Trends
 Table 175. Drug Transdermal Patch Market Drivers
 Table 176. Drug Transdermal Patch Market Challenges
 Table 177. Drug Transdermal Patch Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Transdermal Patch
 Figure 2. Global Drug Transdermal Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Transdermal Patch Market Share by Type: 2024 & 2031
 Figure 4. Duragesic Product Picture
 Figure 5. Exelon Patch Product Picture
 Figure 6. Lindoerm Product Picture
 Figure 7. Mohrus Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Drug Transdermal Patch Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Drug Transdermal Patch Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Global Drug Transdermal Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Drug Transdermal Patch Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Drug Transdermal Patch Sales (2020-2031) & (K Units)
 Figure 16. Global Drug Transdermal Patch Average Price (US$/Unit) & (2020-2031)
 Figure 17. Drug Transdermal Patch Report Years Considered
 Figure 18. Drug Transdermal Patch Sales Share by Manufacturers in 2024
 Figure 19. Global Drug Transdermal Patch Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Drug Transdermal Patch Players: Market Share by Revenue in Drug Transdermal Patch in 2024
 Figure 21. Drug Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Drug Transdermal Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Drug Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 24. North America Drug Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 25. United States Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Drug Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 28. Europe Drug Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Drug Transdermal Patch Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Drug Transdermal Patch Revenue Market Share by Region (2020-2031)
 Figure 36. China Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Drug Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Drug Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Drug Transdermal Patch Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Drug Transdermal Patch Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Drug Transdermal Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Drug Transdermal Patch by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Drug Transdermal Patch by Type (2020-2031)
 Figure 55. Global Drug Transdermal Patch Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Drug Transdermal Patch by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Drug Transdermal Patch by Application (2020-2031)
 Figure 58. Global Drug Transdermal Patch Price (US$/Unit) by Application (2020-2031)
 Figure 59. Drug Transdermal Patch Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions